Published in Am J Med on April 17, 1989
Pharmacology of the calcium antagonist isradipine. Drugs (1990) 0.76
Experimental studies with isradipine in stroke. Drugs (1990) 0.75
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet (2005) 4.88
Editorial peer review for improving the quality of reports of biomedical studies. Cochrane Database Syst Rev (2007) 4.12
Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev (2006) 2.59
Neuron loss in APP transgenic mice. Nature (1998) 2.38
Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A (1999) 2.16
Neuropathology in mice expressing human alpha-synuclein. J Neurosci (2000) 2.06
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (2000) 1.92
Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci (2001) 1.51
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. Br J Pharmacol (1983) 1.48
Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol (1988) 1.40
Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits. Br J Pharmacol (1985) 1.35
Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol (2001) 1.34
MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med (2003) 1.21
Quantitative and qualitative assessment of articular cartilage in the goat knee with magnetization transfer imaging. Magn Reson Imaging (2001) 1.21
PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol (1984) 1.19
Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol Aging (1996) 1.12
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med (2001) 1.10
Glial cell proliferation in the spinal cord after dorsal rhizotomy or sciatic nerve transection in the adult rat. Exp Brain Res (2000) 1.07
Cardiovascular effects of apamin and BRL 34915 in rats and rabbits. Br J Pharmacol (1988) 1.06
In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed (2002) 1.05
Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function. J Biol Chem (1993) 1.05
Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd(DOTA) using dynamic MRI. Magn Reson Imaging (2000) 1.03
Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine. J Cardiovasc Pharmacol (1982) 1.01
Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience (1992) 1.00
Phylogeography of the West Indian manatee (Trichechus manatus): how many populations and how many taxa? Mol Ecol (1998) 1.00
Trapping and intramyocardial distribution of microspheres with different diameters in cat and rabbit hearts in vitro. Basic Res Cardiol (1982) 0.99
Assessing calcium antagonism on vascular smooth muscle: a comparison of three methods. J Pharmacol Methods (1983) 0.96
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. Transplant Proc (2001) 0.95
Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev (2004) 0.95
Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia (1983) 0.95
Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo. J Cardiovasc Pharmacol (1983) 0.94
Calculation of dose coefficients for radionuclides produced in a spallation neutron source utilizing NUBASE and the evaluated nuclear structure data file databases. Health Phys (2006) 0.94
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Mechanism of the vasodilator effects of the cardiotonic agent DPI 201-106. J Cardiovasc Pharmacol (1986) 0.92
Validation studies for the use of the microsphere method in cats and young minipigs. Basic Res Cardiol (1981) 0.92
Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol Exp Ther (1999) 0.92
Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram. Br J Pharmacol (1997) 0.90
Susceptibility to cerebral infarction in the stroke-prone spontaneously hypertensive rat is inherited as a dominant trait. Stroke (1998) 0.90
Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits. Am J Cardiol (1987) 0.89
Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents. NMR Biomed (1999) 0.88
From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research. Anat Rec (2001) 0.88
PY 108-068, a new, potent, and selective inhibitor of calcium-induced contraction of rabbit aortic rings. J Cardiovasc Pharmacol (1982) 0.87
Cloning, distribution and functional expression of the human mGlu6 metabotropic glutamate receptor. Neuropharmacology (1997) 0.86
Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice. Transplantation (1998) 0.86
Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110. J Cardiovasc Pharmacol (1986) 0.86
Very small microspheres are useful for the determination of cardiac output but not organ blood flow in conscious rabbits. Experientia (1981) 0.85
Acceleration of blood in the aorta: a parameter useful for evaluating cardiotonic and afterload reducing substances. J Pharmacol Methods (1981) 0.85
Strain-dependent drug effects in rat middle cerebral artery occlusion model of stroke. J Pharmacol Exp Ther (1995) 0.85
Signal changes in the spinal cord of the rat after injection of formalin into the hindpaw: characterization using functional magnetic resonance imaging. Proc Natl Acad Sci U S A (1997) 0.84
Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. Magn Reson Imaging (2000) 0.84
Magnetic resonance imaging for the evaluation of rejection of a kidney allograft in the rat. Transpl Int (1996) 0.84
Effect of gamma radiation on native endolithic microorganisms from a radioactive waste deposit site. Radiat Res (1999) 0.84
Effects of calcium antagonists on high-energy phosphates in ischemic rat brain measured by 31P NMR spectroscopy. Magn Reson Med (1987) 0.84
A simple cutter for fresh tissue to facilitate the investigation of intramyocardial blood flow with tracer microspheres in cats and rabbits. J Pharmacol Methods (1982) 0.83
Visualization of adenosine A1 receptors in the human and the guinea-pig kidney. Eur J Pharmacol (1987) 0.83
Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRI. NMR Biomed (2000) 0.83
Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo. Eur J Neurosci (1995) 0.83
PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity. Gen Pharmacol (1985) 0.83
Quantification of optic nerve blood flow changes using magnetic resonance imaging. Invest Ophthalmol Vis Sci (1995) 0.83
The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats. Br J Pharmacol (1984) 0.82
Effects of bromocriptine on the heart and the peripheral circulation of anesthetized cats. J Cardiovasc Pharmacol (1984) 0.81
Bicuculline-induced brain activation in mice detected by functional magnetic resonance imaging. Magn Reson Med (2001) 0.81
Muscarinic cholinergic receptors in the rat caudate-putamen and olfactory tubercle belong predominantly to the m4 class: in situ hybridization and receptor autoradiography evidence. Neuroscience (1991) 0.81
Longitudinal in vivo imaging of bone formation and resorption using fluorescence molecular tomography. Bone (2012) 0.81
A smooth muscle cell line suitable for the study of voltage sensitive calcium channels. Biochem Biophys Res Commun (1985) 0.81
Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivo. Neuropharmacology (1996) 0.81
Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart. Am J Cardiol (1987) 0.81
Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals. Am J Med (1989) 0.81
Calcium antagonists for reduction of brain damage in stroke. J Cardiovasc Pharmacol (1990) 0.80
Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. Stroke (1987) 0.80
Pharmacological MRI: a nebulous concept. Trends Pharmacol Sci (2000) 0.80
Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy. Allergy (2011) 0.80
Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Transpl Immunol (2001) 0.80
Incubation media for routine laboratory work on enzyme histotopochemistry. Beitr Pathol (1971) 0.80
Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation (2000) 0.79
The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man. NMR Biomed (2000) 0.79
Muscarinic M2-selective ligands also recognize M4 receptors in the rat brain: evidence from combined in situ hybridization and receptor autoradiography. Synapse (1992) 0.79
Pharmacological inhibition of restenosis: learning from experience. Trends Pharmacol Sci (1995) 0.79
Effect of spirapril on left ventricular hypertrophy due to volume overload in rats. J Cardiovasc Pharmacol (1992) 0.79
Coronary ligation-reperfusion arrhythmia models in anesthetized rats and isolated perfused rat hearts concentration-effect relationships of lidocaine. J Pharmacol Methods (1986) 0.79
Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat. Blood Press (1993) 0.78
Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imaging. J Cardiovasc Pharmacol (1993) 0.78
Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage. Neuropharmacology (2000) 0.78
Chronic graft loss: dealing with the vascular alterations in solid organ transplantation. Transplant Proc (1998) 0.78
Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties. Am J Cardiol (1987) 0.78
Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype. Eur J Pharmacol (1986) 0.78
Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitors. J Med Chem (1995) 0.78
Effects of the enantiomers of the dihydropyridine derivative 202-791 on contractility, coronary flow and ischemia-related arrhythmias in rat heart. Eur J Pharmacol (1986) 0.78